Osteosarcoma is a type of cancer that starts in the bone-forming cells. It usually occurs in the long bones, like the thigh or upper arm, most often in teenagers and young adults. It's the most common type of bone cancer.
Every report comes from a Lived member, sent anonymously.
Have you tried Adriamycin (Doxorubicin) for Osteosarcoma?
Osteosarcoma is a cancer that starts in the cells that build new bone. It is the most common cancer that begins in bone, although it is still rare: about 1,000 people are diagnosed with it each year in the United States. It usually forms in the long bones of the arms and legs, and more than half of cases start in the bones around the knee. The upper arm near the shoulder is another common site. Most people with osteosarcoma are teenagers and young adults, but it can occur at any age, and about 1 in 5 cases occur in people over 60. The first sign is usually pain in a bone or joint, sometimes with a lump or swelling. Because osteosarcoma can spread, most often to the lungs, it is treated as a serious cancer from the start, even when it appears to be confined to one bone. Osteosarcoma is different from cancer that has spread to the bones from somewhere else, such as the prostate or breast. It is also different from other bone cancers, such as Ewing sarcoma and chondrosarcoma, which are treated in other ways.
For most people with osteosarcoma, there is no known cause. The cancer arises from changes in the DNA of bone cells that usually happen by chance, and most people who develop it have none of the known risk factors. Its peak during the teenage years, and a higher risk in people who are taller than average, suggest that factors involved in bone growth play a role. The clearest outside cause is radiation therapy given for an earlier cancer, which raises the risk of osteosarcoma in the treated area years later, especially when treatment was given at a young age or in high doses. Some inherited conditions also raise the risk. These include hereditary retinoblastoma (an eye cancer of early childhood caused by a change in the RB1 gene) and Li-Fraumeni syndrome (an inherited change in the TP53 gene that raises the risk of several cancers). In older adults, osteosarcoma sometimes develops in bone affected by Paget disease, a condition in which bone breaks down and rebuilds abnormally. Apart from radiation, there are no known lifestyle or environmental causes and no known way to prevent osteosarcoma. When a person or family has a pattern of cancers at young ages, a doctor may suggest genetic counseling or testing.
Assessment starts with the history of the pain or swelling and an examination of the area, including how well the nearby joint moves. An X-ray is usually the first test, and a bone tumor often has a recognizable appearance on it. An MRI scan then shows how far the tumor extends through the bone and into nearby muscle, nerves and blood vessels, and whether there are separate small tumors elsewhere in the same bone. That map is what the surgeon later uses to plan the operation. Imaging can strongly suggest osteosarcoma, but only a biopsy, in which a sample of the tumor is removed and examined under a microscope, can confirm it. Where and how the biopsy is done matters: a poorly placed biopsy can make it harder to save the limb later. For this reason it should be planned with, and ideally done by, the surgical team that will remove the tumor, at a center experienced in bone tumors. The pathologist also grades the tumor. High-grade tumors, the most common kind, grow and spread quickly and need chemotherapy. Low-grade tumors grow slowly and may need surgery alone. Once the diagnosis is confirmed, a CT scan of the chest looks for spread to the lungs, and a bone scan or a PET scan (an imaging test that uses a small amount of radioactive sugar to highlight active tumor) looks for spread to other bones. Rather than numbered stages, doctors mainly group osteosarcoma as localized (still confined to the bone where it began) or metastatic (spread elsewhere). About 1 in 5 people already have spread when first diagnosed, usually without symptoms from it. No blood test can diagnose osteosarcoma, although high levels of alkaline phosphatase or lactate dehydrogenase (LDH) can suggest more advanced disease.
Treatment is best planned by a team that specializes in bone cancers, usually including a cancer specialist (oncologist), an orthopedic surgeon experienced with bone tumors and rehabilitation staff. For the common high-grade form, the core of treatment is chemotherapy combined with surgery. Chemotherapy is usually given for several weeks before surgery, which can shrink the tumor and also targets cancer cells that may already have spread but are too small to see. Surgery then removes the whole tumor with a margin of healthy tissue around it, and more chemotherapy follows. Before chemotherapy became standard, the cancer often came back after surgery alone, usually in the lungs. In children, teens and young adults, the usual combination is high-dose methotrexate, doxorubicin and cisplatin, known as MAP after the drugs' initials. Older adults more often receive doxorubicin and cisplatin. These are intensive treatments given in repeated cycles, each lasting a few weeks. They commonly cause nausea, hair loss, mouth sores and low blood counts that raise the risk of infection. Some effects can last: doxorubicin can weaken the heart muscle, cisplatin can damage hearing, and some of the drugs used can affect fertility, so options for preserving fertility are worth discussing before treatment starts. For tumors in an arm or leg, most people can have limb-sparing surgery, which removes the diseased section of bone and replaces it with a metal implant, a bone graft or both. Amputation is sometimes the better choice, for example when the tumor has grown into major nerves or blood vessels. For some tumors around the knee, rotationplasty is an option: after the tumor is removed, the lower leg is turned and reattached so the ankle works as a knee joint inside a prosthesis. Survival is the same whether the first surgery saves the limb or not, so the decision rests on what can be removed safely, expected function, activity goals and the likelihood of future operations. Implants in growing children can often be lengthened without surgery, but may still need replacing later. Radiation does not kill osteosarcoma cells easily, so it is used mainly when surgery cannot remove all of the tumor, as can happen in the spine or skull, or to relieve pain. When cancer has spread to the lungs, removing those tumors surgically along with chemotherapy can still offer a chance of cure. Clinical trials are an important option, particularly when the cancer has spread or comes back.
Treatment for high-grade osteosarcoma is long and demanding. Chemotherapy cycles, surgery and recovery interrupt school, work and social life, and the effects tend to be greatest during the first year. Because the disease often strikes during adolescence, changes in how a young person looks, moves and sees themselves can be hard, and families, including siblings, feel the strain too. Social workers, psychologists and other survivors can help. Rehabilitation is a central part of recovery. After limb-sparing surgery on a leg, it takes about a year on average to relearn to walk, and the rehabilitation is more intensive than after amputation. After a leg amputation, many people walk on their own with a prosthesis within 3 to 6 months of physical therapy. A reconstructed limb may come with some limits on physical activity, and implants can loosen, break or become infected, so further operations over the years are possible. Growing children need prostheses adjusted or replaced as they grow. Outlook depends most on whether the cancer has spread. For people whose cancer is localized at diagnosis, about 60 to 75 percent live at least five years, and many of them are cured. When it has already spread, survival rates are lower, roughly 5 to 30 percent, depending on where it has spread and whether those tumors can be removed. How much of the tumor the chemotherapy destroyed before surgery, and whether surgery removed all of it, also shape the outlook. When osteosarcoma comes back, it is usually within about 18 months of finishing treatment, most often in the lungs or another bone. Follow-up visits with chest imaging and scans of the treated area are frequent at first and become less frequent over time. Because some effects of treatment appear years later, survivors need long-term follow-up that can include heart ultrasounds (echocardiograms), hearing tests, checks on the growth of the treated limb, attention to fertility and awareness of a small increased risk of a second cancer such as leukemia. A written survivorship care plan summarizing the treatment and recommended checks helps any future doctor.
See a doctor if bone or joint pain lasts more than a few weeks or keeps getting worse, especially pain that is worse at night or disturbs sleep, a lump or swelling over a bone, or a limp without a clear cause. Most limb pain in active children and teens comes from ordinary bumps and strains, but pain that does not settle should be examined rather than assumed to be a sports injury. Adults should be checked sooner, because this kind of bone pain is less expected at older ages. Seek same-day care if a sore limb suddenly becomes much more painful or a bone breaks with little or no injury, since a tumor can weaken bone enough to fracture. During chemotherapy, call the cancer care team right away for a fever of 100.5°F (38°C) or higher, chills, or redness or swelling where a catheter enters the body, because infections while white blood cell counts are low can be life threatening. Check with the team before taking acetaminophen or ibuprofen for a fever, since these can hide it. After treatment, tell the care team about a new cough, trouble breathing, chest pain, or new pain or swelling in the treated area or another bone, rather than waiting for the next scheduled visit.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Osteosarcoma is like, what's helped you, or ask the community a question.